Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia (Q37078047)

18 August 2017

1 reference

title

Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia (English)

1 reference

18 August 2017

0 references

0 references

0 references

Anilkumar Pillai

1

1 reference

18 August 2017

5 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

16

1 reference

18 August 2017

2-3

1 reference

18 August 2017

183-193

1 reference

Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS.

18 August 2017

1 reference

Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor

21 January 2018

1 reference

Critical periods during sensory development

21 January 2018

1 reference

Neurotrophins and schizophrenia.

21 January 2018

1 reference

The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia

21 January 2018

1 reference

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning

21 January 2018

1 reference

Brain-derived neurotrophic factor: subcellular compartmentalization and interneuronal transfer as visualized with anti-peptide antibodies

21 January 2018

1 reference

Physiology of BDNF: focus on hypothalamic function

21 January 2018

1 reference

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

Inositol phosphates and cell signalling

21 January 2018

1 reference

Rapid phosphorylation of phospholipase C gamma 1 by brain-derived neurotrophic factor and neurotrophin-3 in cultures of embryonic rat cortical neurons

21 January 2018

1 reference

Trk receptors: roles in neuronal signal transduction

21 January 2018

1 reference

The activation of Akt/PKB signaling pathway and cell survival.

21 January 2018

1 reference

Increasing complexity of Ras signaling.

21 January 2018

1 reference

Advancing a neurodevelopmental origin for schizophrenia

21 January 2018

1 reference

On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia

21 January 2018

1 reference

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

21 January 2018

1 reference

Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems

21 January 2018

1 reference

Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia.

21 January 2018

1 reference

Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb

21 January 2018

1 reference

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

21 January 2018

1 reference

Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains.

21 January 2018

1 reference

Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.

21 January 2018

1 reference

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients.

21 January 2018

1 reference

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.

21 January 2018

1 reference

Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.

21 January 2018

1 reference

Brain derived neurotropic factor in first-episode psychosis

21 January 2018

1 reference

Schizophrenia, III: brain-derived neurotropic factor and genetic risk.

21 January 2018

1 reference

Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.

21 January 2018

1 reference

Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis

21 January 2018

1 reference

The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia

21 January 2018

1 reference

COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study.

21 January 2018

1 reference

Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics.

21 January 2018

1 reference

No association of the brain-derived neurotrophic factor (BDNF) gene C-270T polymorphism with schizophrenia.

21 January 2018

1 reference

Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study

21 January 2018

1 reference

An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients

21 January 2018

1 reference

BDNF gene is a risk factor for schizophrenia in a Scottish population.

21 January 2018

1 reference

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.

21 January 2018

1 reference

No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population.

21 January 2018

1 reference

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

Do we still believe in the dopamine hypothesis? New data bring new evidence

21 January 2018

1 reference

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

21 January 2018

1 reference

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

A separate disease within the syndrome of schizophrenia

21 January 2018

1 reference

21 January 2018

1 reference

Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.

21 January 2018

1 reference

Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders

21 January 2018

1 reference

GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia

21 January 2018

1 reference

Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications

21 January 2018

1 reference

Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia.

21 January 2018

1 reference

Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo

21 January 2018

1 reference

BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex.

21 January 2018

1 reference

To model a psychiatric disorder in animals: schizophrenia as a reality test

21 January 2018

1 reference

Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis

21 January 2018

1 reference

Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia.

21 January 2018

1 reference

Neonatal damage of the ventral hippocampus impairs working memory in the rat.

21 January 2018

1 reference

Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

21 January 2018

1 reference

Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus

21 January 2018

1 reference

Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.

21 January 2018

1 reference

Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels

21 January 2018

1 reference

Chronic amphetamine treatment reduces NGF and BDNF in the rat brain.

21 January 2018

1 reference

Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain

21 January 2018

1 reference

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.

21 January 2018

1 reference

Haloperidol treatment decreases nerve growth factor levels in the hypothalamus of adult mice.

21 January 2018

1 reference

Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol

21 January 2018

1 reference

Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats.

21 January 2018

1 reference

Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine

21 January 2018

1 reference

Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions.

21 January 2018

1 reference

Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

21 January 2018

1 reference

Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs

21 January 2018

1 reference

Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats

21 January 2018

1 reference

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

21 January 2018

1 reference

Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus

21 January 2018

1 reference

Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity

21 January 2018

1 reference

Post-stress changes in BDNF and Bcl-2 immunoreactivities in hippocampal neurons: effect of chronic administration of olanzapine

21 January 2018

1 reference

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

21 January 2018

1 reference

Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism.

21 January 2018

1 reference

Antipsychotic drug effects on brain morphology in first-episode psychosis

21 January 2018

1 reference

Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms.

21 January 2018

1 reference

In vivo evidence that erythropoietin protects neurons from ischemic damage

21 January 2018

1 reference

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

21 January 2018

1 reference

Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity

21 January 2018

1 reference

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

21 January 2018

1 reference

Therapeutic possibilities of cysteamine in the treatment of schizophrenia

21 January 2018

1 reference

The effects of cysteamine on dopamine-mediated behaviors: evidence for dopamine-somatostatin interactions in the striatum.

21 January 2018

1 reference

Intra-cerebral cysteamine infusions attenuate the motor response to dopaminergic agonists

21 January 2018

1 reference

Cysteamine blocks amphetamine-induced deficits in sensorimotor gating

21 January 2018

1 reference

Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells

21 January 2018

1 reference

Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia

21 January 2018

1 reference

Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory and brain neurochemistry

21 January 2018

1 reference

Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonists

21 January 2018

1 reference

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

21 January 2018

1 reference

The effects of dietary n-3/n-6 ratio on brain development in the mouse: a dose response study with long-chain n-3 fatty acids

21 January 2018

1 reference

Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology

21 January 2018

1 reference

Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia

21 January 2018

1 reference

n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism.

21 January 2018

1 reference

Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

21 January 2018

1 reference

BDNF gene variants and brain morphology in schizophrenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000111562

1 reference

18 August 2017

1 reference

PubMed ID

18253057